The i.p. administration of AM841 at the effective dose in wild type animals (0.1 mg/kg, once daily) did not attenuate the DSS-induced colitis in CB1-/- (Fig. 2A), CB2-/- (Fig. 2B) or CB1/2-/- mice (Fig. 2C). This evidence concerns the gene CNR2 and colitis.